During the past decade, Oftar Centro Privado de Oftalmologia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Oftar Centro Privado de Oftalmologia" are "Glaucoma, Open-Angle" (1 trials), "Macular Degeneration" (1 trials) and "Ocular Hypertension" (1 trials). Many other conditions were trialed in "Oftar Centro Privado de Oftalmologia" in a lesser frequency.

Most popular intervention types in "Oftar Centro Privado de Oftalmologia" are "Drug" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Abicipar Pegol" (1 trials), "Active Comparator: Timolol 0.5%" (1 trials), "Bimatoprost SR" (1 trials), "Ranibizumab" (1 trials) and "Sham Procedure" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oftar Centro Privado de Oftalmologia" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Oftar Centro Privado de Oftalmologia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Oftar Centro Privado de Oftalmologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oftar Centro Privado de Oftalmologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".